Recent research has also proposed a role for Fn-derived bacterial metabolites, such as riboflavin, in shaping the tumour microenvironment by activating mucosal-associated invariant T (MAIT) cells, which drive pro-inflammatory signalling linked to CRC progression (Li et al., 2020). This evidence concerns the gene FN1 and colorectal carcinoma.